We report autoradiographic measurements of the in vivo uptake of eHJnimodipine during the nonischemic de polarization of cortical spreading depression (CSD) in rat brain.
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[3HJNimodipine uptake in brain was determined regionally in rats undergoing CSD (n = 8) and was significantly increased in cortex (14 ± 7%) and hippocampus (10 ± 6%) on the stimu lated side relative to the contralateral hemisphere when com pared with the same measurements in a control group (n = 8). A similar measurement using the physiologically inert radio tracer e4Cj iodoantipyrine to control for potential effects of Cortical spreading depression (CSD) is a reversible wave of depressed electrocortical activity and direct cur rent (DC) depolarization that propagates across the ce rebral cortex at a characteristic rate of 3 mm/min (Leao, 1944) . The brief period of brain tissue depolarization is associated with massive shifts of K+ out of cells and Na+, CC Ca2+ and water into cells (see review by Somjen et aI., 1992) . Excitatory neurotransmission and calcium channel activation may be factors in CSD. Cortical spreading depression is reduced or completely sup pressed with N-methyl-D-aspartate receptor antagonists (Lauritzen and Hansen, 1992; McLachlan, 1992) and blockade of voltage-sensitive calcium channels (VSCC) prevents K+ induced spreading depression in hippocam pal slice preparations (Jing et aI., 1993) .
We have previously shown increased in vivo binding of the 1 A-dihydropyridine L-type VSCC antagonist eH]nimodipine to the L-type VSCC in acutely ischemic 586 CSD on radioligand distribution showed a minimal increase (2.4 ± 0.7%) of radiotracer uptake in cortex after CSD. This increase was significantly less than that observed in the [3HJni modipine uptake studies. We hypothesize that increased in vivo eHJnimodipine uptake in CSD identifies regions of depolar ization and thus infers activation of the L-type voltage sensitive calcium channels. Key Words: Cortical spreading depres sion-voltage sensitive calcium channels-nimodipine autoradiography.
brain by using quantitative autoradiography Hogan et aI., 1991) . We proposed that increased in vivo uptake of eH]nimodipine into ischemic brain was a consequence of the greater affinity of the L-type VSCC in depolarized cell membranes to bind l,4-dihydropyridine VSCC antagonists (Kokubun et aI., 1986; Triggle and Rampe, 1989) thus inferring activation of this channel. If this hypothesis is correct in vivo uptake of eH]nimodipine should increase during the nonisch emic depolarization associated with CSD.
METHODS
Adult male Sprague Dawley rats were fasted overnight be fore study. Halothane anesthesia (4% induction, 0.5% mainte nance) was maintained throughout surgery and during recurrent CSD.
eH]Nimodipine binding during cortical spreading depression
Mean arterial blood pressure and arterial blood gases were monitored in spontaneously breathing rats. Body temperature was maintained between 36 and 37°C. Burr holes were placed stereotactically over the right occipital and right frontal corti ces. A microdialysis probe was inserted 2 mm into the right occipital cortex. To record CSD, a 13 /.1m-diameter, platinum wire electrode was inserted 2 mm into the right frontal cortex and connected to a DC amplifier (Gould Instruments Inc., Val ley View, OH, U.S.A.). In 8 rats CSD was induced by infusion of 3 mol/L KCI solution through the microdialysis probe at a starting rate of 2 /.1L!min. Control animals (n = 8) were infused NIMODIPlNE UPTAKE IN SPREADING DEPRESSION 587 with nonnal saline at the same rate. After 60 minutes of recur rent CSD, 200 j.LCi of eHJnimodipine (specific activity 130 Ci/mmol, NEN-Dupont, Boston, MA, U.S.A.) in 600 j.LL of carrier (BAY e9736 placebo, Miles Phannaceuticals, Etobi coke, Ontario, Canada) were infused intravenously over 3 min utes at the start of the next recorded DC potential shift. In control studies the radiotracer was infused after 60 minutes of nonnal saline perfusion of the microdialysis probe. After 15 minutes of radiotracer circulation plasma, eHJnimodipine ac tivity was measured, the rat was decapitated, and the brain was immediately removed and frozen at -70°C. e4C]Iodoantipyrine uptake during cortical spreading depression eHJNimodipine freely crosses the blood brain barrier (Van den Kerckhoff and Drewes, 1985) and its initial clearance may be influenced by cerebral blood flow (CBF) changes during CSD. To assess for this possible effect, the uptake of the physi ological inert and blood brain barrier penneable radiotracer e4C]Jodoantipyrine (Sakurada et aI., 1978) was measured. Probe placements were identical to the eHJnimodipine studies. After 60 minutes of either recurrent CSD (n = 6) or saline perfusion (n = 6) 30 j.LCi of e4C]Iodoantipyrine (specific ac tivity 57 mCi/mmol, Amersham International PLC, England) in 600 j.Ll of nonnal saline were infused over 3 minutes at the start of the next recorded CSD. After 15 minutes of radiotracer circulation plasma e4C]Iodoantipyrine activity was measured, the rat was decapitated, and the brain was rapidly removed and frozen at -70°C. To better control arterial Pco2 and associated CBF changes, these rats were mechanically ventilated with 30% O2 to 70% N20 in addition to halothane.
Autoradiography
Horizontal cryostat brain sections 20-j.Lm thick were ob tained every 140 j.Lm and apposed to tritium sensitive film (Hyperfilm, Amersham, Oakville, Ontario, Canada) for eHJni modi pine studies or Kodak SB-5 film (Picker International, Brampton, Ontario, Canada) for [14C]iodoantipyrine studies. Tritium autoradiographs were calibrated using tissue paste standards prepared in the laboratory from forebrain homog enates. Microscale standards (Amersham International PLC, England) were used to calibrate the 14C autoradiographs. Au toradiographs were digitized (Imaging Research Inc., St. Ca tharines, Ontario, Canada) and regional radiotracer concentra tions detennined using a standardized region of interest tem plate at five horizontal levels (Fig. 1) . The observer was blinded to the treatment status of the rats. Previously deter mined metabolite corrections (Hogan et aI., 199 and [3HJnimodipine volume of distribution calculated as the ratio of tissue [3HJnimodipine over plasma [3HJnimodipine concentration (Lassen and Perl, 1979) .
Data analysis and statistics
Physiological data comparisons were performed using inde pendent t tests. The ratio of the volume of distribution of eHlnimodipine in the stimulated hemisphere over that in the contralateral hemisphere was calculated for each region of in terest. Striatal and hippocampal regions of interest data were grouped and K-means cluster analysis (Hartigan and Wong, 1979) was used 'to subdivide the cortical regions of interest into three groups. All subsequent analysis used data averaged over these five volumes of interest (Fig. 1) . The Mann-Whitney U test (BMDP Statistical Software, Inc., Los Angeles, CA, U.S.A.) with Bonferonni correction was used to assess differ ences between the CSD and control groups.
RESULTS

Physiologic measurements
Mean arterial blood pressure and arterial blood gases did not differ between the CSD and control groups in the [ 3 H]nimodipine and C 4 C]iodoantipyrine studies. Peo2 was lower and better controlled in the e 4 C]iodoantipy rine studies.
Cortical spreading depression
Recurrent DC potential shifts with initial negative de flection of 1 to 5 m V of 30 to 60 seconds duration con sistent with CSD depolarization (Somjen et aI., 1992; McLachlan, 1992) were recorded from the frontal cortex. In the eH]nimodipine CSD group, 8.0 ± 2.6 DC depo- larizations were recorded whereas in the e 4 C]iodoanti pyrine CSD group, 9.0 ± 2.2 DC depolarizations were observed. In the r 3 H]nimodipine studies only one DC depolarization was observed after eH]nimodipine infu sion whereas in the C 4 C]iodoantipyrine studies six DC depolarizations were observed in five rats after radio tracer infusion. One DC depolarization was observed in the [ 3 H]nimodipine control group. Figure 2 shows autoradiographs of in vivo uptake of eH]nimodipine into brain in four horizontal sections (corresponding to the first four levels in Fig. 1 ) from a selected study in the recurrent CSD group. The stimu lated hemisphere is on the left side of these images.
eH]Nimodipine binding
[ 3 H]Nimodipine uptake was increased in both cortex and hippocampus of the CSD-stimulated hemisphere relative to the contralateral hemisphere. No change was observed in striatum. The narrow margin of intense eH]nimo dipine uptake around the microdialysis probe was ex cluded from analysis. The ratio of eH]nimodipine up take in the stimulated hemisphere over the contralateral hemisphere for each volume of interest is summarized in Table 1 . This ratio was increased in cortex I by 14% (p = 0.019), in cortex 2 by 11 % (p = 0.031), and in the hippocampus by lO% (p = 0.016) in the CSD group compared with the control group. In the control group, the average cortical eH]nimodipine volume of distribu tion was lO4 ± 20 mL/I00 g and was 112 ± 17 mL/lOO g in the striatum and 125 ± 23 mL/I00 g in the hippo campus. Volumes of distribution in the contralateral hemisphere did not differ between control and CSD stud ies.
e4C]Iodoantipyrine uptake
Ratios of e 4 C]iodoantipyrine uptake in the stimulated hemisphere over the contralateral hemisphere for each volume of interest ranged from 1.005 ± 0.015 to 1.035 ± 0.027 in the control group and from 1.031 ± 0.006 to 1.065 ± 0.042 in the CSD group. This ratio was only increased in cortex 1 by 2.4% (p = 0.032) in the CSD group compared with the control group. This increased uptake of e 4 C]iodoantipyrine within cortex 1 was sig nificantly less than the increase observed for eH]nimo dipine uptake within the same region (p = 0.02).
DISCUSSION
We have shown increased in vivo eH]nimodipine up take in the cortex and hippocampus ipsilateral to recur rent CSD in rat brain. Only a minimal increase in the cortex was observed with the physiologically inert radio tracer [ 14 C]iodoantipyrine administered in an identical manner. We hypothesize that increased eH]nimodipine uptake is a consequence of cell-membrane depolarization indicating activation of the L-type VSCC during CSD. We have previously shown increased in vivo uptake of eH]nimodipine in ischemic brain with kinetics of in vivo binding consistent with saturable and specific binding to the L-type VSCC . This increased uptake is rapidly reversible with restoration of CBF (Hogan and Hakim, 1992; Takizawa et aI, 1994) and we concluded that in vivo eH]nimodipine binding may be used to identify transient cell-membrane depolarization and thus infer ac tivation of the L-type VSCc. The current study extends these observations to a model of nonischemic depolar ization in which interpretation of binding changes is not confounded by severe CBF depression and histologic injury.
The 14% increase of eH]nimodipine uptake during CSD is less than the 90% increase observed in irrevers ible focal cerebral ischemia . In ischemia, tissue depolarization is continuous whereas CSD produces an intense but transient depolarization. In vivo binding of eH]nimodipine to the L-type VSCC may require up to 30 minutes to reach equilibrium (Hogan et ai., 1991) . Binding to the L-type VSCC is reversible with dissociation occurring over minutes in membrane frac tion preparations (Glossmann and Ferry, 1985) . The cur rent experimental design was a compromise between at taining equilibrium of distribution of radiotracer between plasma and brain but preventing complete dissociation of [ 3 H]nimodipine bound to the L-type VSCC after repo larization. Only a fraction of the available binding sites during depolarization may be expected to remain la belled at study termination and our observations will underestimate the degree of depolarization during CSD. Cerebral blood flow may increase by 100% during the initial depolarization of CSD (Hansen et ai., 1980) but subsequently CBF decreases to approximately 70% of control values (Lauritzen et ai., 1982; Duckrow, 1991) . The in vivo uptake of [ 14 C]iodoantipyrine administered in an identical manner to eH]nimodipine showed only a small increase in cortical uptake after CSD. This increase was significantly less than the more widespread increase observed with eH]nimodipine despite a greater number of CSD depolarizations after radiotracer administration in the [ 14 C]iodoantipyrine studies. We have previously observed that eH]nimodipine distribution between brain and plasma was not impaired even with marked CBF reduction . Thus increased r 3 H]nimo dipine uptake 15 minutes after CSD is not a consequence of CBF fluctuations. The blood volume in brain has been estimated to be 3.4 to 4.5 mL/I00 g for the range of arterial Pc02 values observed in these studies (Schockley and LaManna, 1988) . The 14 mL/ lOO g increase in eH]nimodipine uptake following CSD cannot be attrib uted to changes in this volume. Tissue injury may alter nonspecific binding of eH]nimodipine (Hogan et aI, 1991 ) but pathological changes are not observed in CSD (Nedergaard and Hansen, 1988) . Thus we hypothesize that the increased uptake of eH]nimodipine observed in this study is a consequence of transient depolarization during CSD and is an indirect indication of L-type VSCC activation.
In cerebral ischemia, CSD may be harmful by increas ing the energy demands of tissue in the peri-infarct bor der zone (Mies et al., 1993) . Ischemia-induced CSD may explain the small increase in eH]nimodipine uptake pre viously report4(l in the cingu late cortex adjacent to ischemic brain in a rat model of middle cerebral artery occlusion. It has also been ob served that CSD may induce a delayed neuroprotection to subsequent ischemia (Kawahara et al; Mat sushima et al., 1996) . Both CSD and calcium-channel activation will induce immediate early gene expression (Herrera and Robertson, 1990, Murphy et al., 1991) and may underlie the molecular changes observed in CSD. Thus, the phenomenon of CSD with its nonischemic ac tivation of calcium channels may be a useful experimen tal tool to further probe the metabolic and molecular responses involved in neuronal survival in neurological disease.
